tak-850
Vaccineexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2014 (NCT02111252)
Timeline
Indications
Mechanism of action
- Toll-like receptor 4INHIBITOR
TLR4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tak-850
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02713061 | Phase 2 | Mar 1, 2016 | Takeda |
| NCT02555618 | Phase 2 | Sep 1, 2015 | Takeda |
| NCT02367885 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2015 | Takeda |
| NCT02313155 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2014 | Takeda |
| NCT02111252 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2014 | Takeda |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Takeda | For profit | 5 | 5 | 1 | 2014 |
1 organizations
Page 1 / 1